FDA Approval and Labeling*

Pain palliation of metastatic bone cancer in patients 18 years of age or older who are suffering from bone pain due to metastatic diseases and who are failures of standard radiation therapy, or not candidates for, or refused radiation therapy. The bone tumor to be treated must be visible on a non-contrast MR and device accessible.